Advertisement
Screener

SPARK THERAPEUTICS, INC. Net Income

SPARK THERAPEUTICS, INC. Net Income

SPARK THERAPEUTICS, INC. reported Net Income of -$66.60 million for the 3-month period ending 2019-09-30, per its 10-Q filed 2019-11-07.

Discontinued › Income Statement › Net Income

us-gaap:NetIncomeLoss · last filed 2019-11-07

  • SPARK THERAPEUTICS, INC. net income (loss) attributable to parent for the quarter ending 2019-09-30 was -$66.60M.
  • SPARK THERAPEUTICS, INC. net income (loss) attributable to parent for the quarter ending 2019-06-30 was -$64.23M, a 180.12% decline year-over-year.
  • SPARK THERAPEUTICS, INC. net income (loss) attributable to parent for the quarter ending 2019-03-31 was -$54.36M.
  • SPARK THERAPEUTICS, INC. net income (loss) attributable to parent for the quarter ending 2018-12-31 was -$65.26M.
  • SPARK THERAPEUTICS, INC. net income (loss) attributable to parent for fiscal 2018 was -$78.82M.
  • SPARK THERAPEUTICS, INC. net income (loss) attributable to parent for fiscal 2017 was -$253.48M.
  • SPARK THERAPEUTICS, INC. net income (loss) attributable to parent for fiscal 2016 was -$123.65M.
  • SPARK THERAPEUTICS, INC. net income (loss) attributable to parent for fiscal 2015 was -$47.13M.
Period endNet Income (Loss) Attributable to Parent 3 monthNet Income (Loss) Attributable to Parent 3 month as first filedNet Income (Loss) Attributable to Parent 6 monthNet Income (Loss) Attributable to Parent 6 month as first filedNet Income (Loss) Attributable to Parent 9 monthNet Income (Loss) Attributable to Parent 9 month as first filedNet Income (Loss) Attributable to Parent 10 monthNet Income (Loss) Attributable to Parent 12 monthNet Income (Loss) Attributable to Parent 12 month as first filed
2019-09-30-$66.60M
10-Q · filed 2019-11-07
-$130.83M
derived: sum of 2 quarters · filed 2019-11-07
-$185.19M
10-Q · filed 2019-11-07
-$250.45M
derived: sum of 4 quarters · filed 2019-11-07
2019-06-30-$64.23M
10-Q · filed 2019-08-08
-$118.59M
10-Q · filed 2019-08-08
-$183.84M
derived: sum of 3 quarters · filed 2019-08-08
-$231.20M
derived: sum of 4 quarters · filed 2019-11-07
2019-03-31-$54.36M
10-Q · filed 2019-05-10
-$119.61M
derived: sum of 2 quarters · filed 2019-05-10
-$166.97M
derived: sum of 3 quarters · filed 2019-11-07
-$86.81M
derived: sum of 4 quarters · filed 2019-11-07
2018-12-31-$65.26M
10-K · filed 2019-02-28
-$112.61M
derived: sum of 2 quarters · filed 2019-11-07
-$32.45M
derived: sum of 3 quarters · filed 2019-11-07
-$78.82M
10-K · filed 2019-02-28
2018-09-30-$47.36M
10-Q · filed 2019-11-07
$32.81M
derived: sum of 2 quarters · filed 2019-11-07
-$13.56M
10-Q · filed 2019-11-07
-$75.39M
derived: sum of 4 quarters · filed 2019-11-07
2018-06-30$80.17M
10-Q · filed 2019-08-08
$33.79M
10-Q · filed 2019-08-08
-$28.03M
derived: sum of 3 quarters · filed 2019-08-08
-$93.04M
derived: sum of 4 quarters · filed 2019-08-08
2018-03-31-$46.37M
10-Q · filed 2019-05-10
-$108.19M
derived: sum of 2 quarters · filed 2019-05-10
-$173.21M
derived: sum of 3 quarters · filed 2019-05-10
-$247.57M
derived: sum of 4 quarters · filed 2019-05-10
2017-12-31-$61.82M
10-K · filed 2019-02-28
-$61.82M
10-K · filed 2018-02-27
-$126.83M
derived: sum of 2 quarters · filed 2019-02-28
-$201.19M
derived: sum of 3 quarters · filed 2019-02-28
-$253.48M
10-K · filed 2019-02-28
-$253.48M
10-K · filed 2018-02-27
2017-09-30-$65.01M
10-K · filed 2019-02-28
-$65.01M
10-Q · filed 2017-11-07
-$139.37M
derived: sum of 2 quarters · filed 2019-02-28
-$191.66M
10-Q · filed 2018-11-06
-$191.66M
10-Q · filed 2017-11-07
-$228.50M
derived: sum of 4 quarters · filed 2019-02-28
2017-06-30-$74.36M
10-K · filed 2019-02-28
-$74.36M
10-Q · filed 2017-08-02
-$126.65M
10-Q · filed 2018-08-08
-$126.65M
10-Q · filed 2017-08-02
-$163.49M
derived: sum of 3 quarters · filed 2019-02-28
-$196.05M
derived: sum of 4 quarters · filed 2019-02-28
2017-03-31-$52.29M
10-K · filed 2019-02-28
-$52.29M
10-Q · filed 2017-05-10
-$89.13M
derived: sum of 2 quarters · filed 2019-02-28
-$121.69M
derived: sum of 3 quarters · filed 2019-02-28
-$150.36M
derived: sum of 4 quarters · filed 2019-02-28
2016-12-31-$36.84M
10-K · filed 2018-02-27
-$69.40M
derived: sum of 2 quarters · filed 2018-02-27
-$98.08M
derived: sum of 3 quarters · filed 2018-02-27
-$123.65M
10-K · filed 2019-02-28
-$123.65M
10-K · filed 2017-02-28
2016-09-30-$32.56M
10-K · filed 2018-02-27
-$61.24M
derived: sum of 2 quarters · filed 2018-02-27
-$86.82M
10-Q · filed 2017-11-07
-$92.97M
derived: sum of 4 quarters · filed 2018-02-27
2016-06-30-$28.68M
10-K · filed 2018-02-27
-$54.25M
10-Q · filed 2017-08-02
-$60.41M
derived: sum of 3 quarters · filed 2018-02-27
-$77.31M
derived: sum of 4 quarters · filed 2018-02-27
2016-03-31-$25.58M
10-K · filed 2018-02-27
-$31.73M
derived: sum of 2 quarters · filed 2018-02-27
-$48.63M
derived: sum of 3 quarters · filed 2018-02-27
-$62.97M
derived: sum of 4 quarters · filed 2018-02-27
2015-12-31-$6.15M
10-K · filed 2017-02-28
-$23.06M
derived: sum of 2 quarters · filed 2017-02-28
-$37.39M
derived: sum of 3 quarters · filed 2017-02-28
-$47.13M
10-K · filed 2018-02-27
2015-09-30-$16.90M
10-K · filed 2017-02-28
-$31.24M
derived: sum of 2 quarters · filed 2017-02-28
-$40.97M
10-Q · filed 2016-11-04
-$49.99M
derived: sum of 4 quarters · filed 2017-02-28
2015-06-30-$14.34M
10-K · filed 2017-02-28
-$24.07M
10-Q · filed 2016-08-10
-$33.09M
derived: sum of 3 quarters · filed 2017-02-28
-$39.84M
derived: sum of 4 quarters · filed 2017-02-28
2015-03-31-$9.73M
10-K · filed 2017-02-28
-$18.75M
derived: sum of 2 quarters · filed 2017-02-28
-$25.51M
derived: sum of 3 quarters · filed 2017-02-28
-$29.67M
derived: sum of 4 quarters · filed 2017-02-28
2014-12-31-$9.02M
10-K · filed 2016-03-14
-$15.77M
derived: sum of 2 quarters · filed 2016-03-14
-$19.94M
derived: sum of 3 quarters · filed 2016-03-14
-$24.32M
10-K · filed 2017-02-28
2014-09-30-$6.76M
10-K · filed 2016-03-14
-$10.93M
derived: sum of 2 quarters · filed 2016-03-14
-$15.31M
10-Q · filed 2015-11-06
2014-06-30-$4.17M
10-K · filed 2016-03-14
-$8.55M
10-Q · filed 2015-08-07
2014-03-31-$4.38M
10-K · filed 2016-03-14
2013-12-31-$57.28M
10-K · filed 2016-03-14